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Abstract
Background: SPEM dysfunction is a well-known phenomenon in schizophrenia. The principal aim
of the present study was to examine whether SPEM dysfunction is already observable in subjects
scoring high on a specific measure of schizotypy (SSQ General Schizotypy) that was selected
because of its intimate relationship with schizophrenic prodromal unfolding.
Methods: Applying ANOVAs, we determined the relationship of subjects' scores on SSQ General
Schizotypy and eye movements elicited by targets of different speed. We also examined whether
there exists an association between our schizotypy measure and pupil size.
Results: We found more SPEM dysfunction in subjects scoring high on SSQ General Schizotypy
than in subjects scoring average on that factor, irrespective of the speed of the target. No
relationship was found between baseline pupil size and General Schizotypy.
Conclusion: The present study provides additional evidence that SPEM dysfunction is associated
with schizotypic features that precede the onset of schizophrenia and is already observable in
general population subjects that show these features.
Background
One century ago, Diefendorf and Dodge first described a
phenomenon in schizophrenic patients that is presently
known as smooth pursuit eye movement (SPEM) dysfunc-
tion [1]. Rediscovered in the early 1970s by Holzman et
al. [2], this phenomenon, reflecting an impairment in the
ability to visually track a smoothly moving target, was not
only observed in 60–80% of patients with schizophrenia
[3,4], but also in approximately half of their biological rel-
atives [5,6], and in monozygotic twins who were discord-
ant for schizophrenia [7]. Other studies indicated that
SPEM impairments occur in abnormally high proportions
in patients suffering from schizotypal personality disorder
or SPD [8,9]; these findings are understandable as SPD is
known to be genetically related to schizophrenia [10,11].
Finally, eye tracking impairments have also been observed
in general population subjects with elevated scores on
questionnaire measures of schizotypy [12]. Given the
above-mentioned findings, SPEM dysfunction has been
typically regarded as a neurophysiological marker of the
genetic vulnerability to develop schizophrenia [4,13].
According to Holzman et al. [14], eye tracking disturbance
and schizophrenia are both expressions of a single under-
lying trait that is transmitted as an autosomal dominant
gene. Additional evidence for a single major gene account-
ing for much of the variance in eye tracking performance
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firm conclusions can be drawn as several association and
linkage studies suggest the influence of multiple genes.
Still, in the last ten years, no eye movement dysfunction
related genes for schizophrenia have been definitely iden-
tified [16].
In addition to the general relationship of SPEM abnor-
malities with schizophrenia and SPD, the association
between deviant eye tracking and specific symptoms of
these disorders has been studied. Most studies indicate a
relationship with negative symptoms of schizophrenia
[17-21] and SPD [9,22-24], but a relationship with posi-
tive symptoms and symptoms related to Liddle's disor-
ganization syndrome [25] have also been reported
[5,24,26,27]. Similarly, SPEM dysfunction has been
found in general population subjects with elevated scores
on either positive or negative measures of schizotypy [28-
30]. The close relationship of SPEM dysfunction with neg-
ative symptoms agrees with the notion that the genetic
predisposition to schizophrenia expresses itself predomi-
nantly in negative symptoms [31-36]. However, positive
symptoms may also reflect the genetic basis of schizophre-
nia. In Kendler et al's study, for instance, nearly all schizo-
typal factors, including positive and negative schizotypy,
discriminated relatives of schizophrenic probands from
relatives of controls [33]. Even, elevated rates of only pos-
itive schizotypy have been found in biological relatives of
schizophrenics [37,38]. To explain these conflicting
results, the finding is of interest that individuals with ele-
vated scores on negative and positive schizotypy appear at
particularly high risk for development of schizophrenia,
whereas those with deviant scores on only scales for posi-
tive schizotypy may also develop other types of psychotic
disorder [39]. As negative symptoms precede the emer-
gence of positive symptoms in schizophrenia [40-42], we
may infer that the genetic predisposition to schizophrenia
manifests itself first in negative symptoms. Subsequently,
psychotic-like and psychotic symptoms, may develop
which reflect schizophrenia's pathophysiology and genet-
ics to a lesser degree and only in an indirect way [43].
Concerning the measurement of SPEM dysfunction, some
studies have focused on global ocular motor measures,
whereas others evaluated saccade frequency and pursuit
gain [22]. Formerly, these latter measures have been
reported to be less sensitive than global assessments
[44,45]. Indeed, in a recent meta-analytic review of
smooth pursuit in schizophrenia, global measures, such
as the RMSE, were found to yield larger effect sizes than
specific measures [46]. The discriminative power of the
RMSE may be the product of the inability of the subject to
pursuit the target at the same speed as well as to suppress
the saccade system leading to intrusive saccades. Thus,
although the RMSE has excellent test-retest reliability and
may be useful in screening situations, it is not useful for
clarifying specific deficits [47]. However, as our aim was
not to reveal specific deficits but to relate a robust measure
of SPEM dysfunction with schizotypy, we choose to meas-
ure the RMSE.
In the present study schizotypy was assessed by the gen-
eral factor of Van Kampen's Schizotypic Syndrome Question-
naire (SSQ) [48]. The reason for this choice was twofold.
First, the 12 symptom scales of the SSQ were selected on
basis of previous studies [40,42,49] to describe the main
causal pathways in the process of schizophrenic prodro-
mal unfolding [43,50]. Between the selected symptoms a
detailed network of causal relationships was postulated
against the background of the observation that negative
symptoms precede positive ones. In addition, the 12 SSQ
scales offer a definition of schizotypy (and SPD) with par-
ticular relevance for the study of variables that relate to
both schizotypy and schizophrenia. Second, as the SSQ
higher-order factors Negative Schizotypy, Asocial Schizo-
typy, and Positive Schizotypy appear to be interrelated
[48], the general SSQ factor can be considered to accu-
rately denote what schizotypy is really like. As also nega-
tive and positive schizotypy factors have been found
associated with SPEM dysfunction, we decided to investi-
gate the relationship between schizotypy and SPEM
impairments by using the general SSQ factor. However, it
remains of interest to see that, although all SSQ scales
load the general factor, the highest saturations were
obtained for those scales that define the Negative Schizo-
typy factor of the SSQ [48].
In addition to SPEM performance, schizophrenia has
been associated with a baseline pupil size that correlated
positively with symptom severity as measured by the Brief
Psychiatric Rating Scale and the Hamilton Rating Scale for
Depression, although not with several scales for the meas-
urement of negative and/or positive symptoms [51].
In the present study, the relationship between subjects'
scores on the SSQ and eye movements elicited by targets
of different speed, was established. It was expected that
higher scores on the General Schizotypy factor would be
associated with more apparent SPEM dysfunction, the
magnitude of which being possibly dependent on target
speed. In addition, we examined whether there exists a
relationship between General Schizotypy and pupil size.
What is novel in this study compared to previous ones is
the use of a very particular measure of schizotypy for
mainly theoretical reasons. As such, the present investiga-
tion may also add to the validation of the SSQ model with
its emphasis on a general factor.
Methods
Subjects
The present study forms part of a larger study on the valid-
ity of the SSQ [48]. A number of 495 subjects (290Page 2 of 7
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eral practitioners in Amsterdam, were invited by letter to
fill in the SSQ and the Four-Dimensional Personality Test
(4DPT) [52] that were enclosed in the mail. Subjects were
aged between 20 and 50 years. On the closing date, after
two weeks, 140 SSQ and 4DPT forms had been returned
by 48 male and 92 female subjects. Subjects had a mean
age of 35.97 years (SD = 7.03). Noting that the scores on
the 12 SSQ scales appeared to be somewhat higher than
those obtained in a more representative sample of 557
subjects (all inhabitants of Haarlem and Gouda [43]), the
General Schizotypy scores in the present group were esti-
mated on the basis of a regression equation derived in the
last-mentioned sample. After discarding 9 subjects with
insufficient data to estimate the scores on the first unro-
tated component, three subgroups were formed; 1) a
group of subjects with General Schizotypy scores above 1
SD (n = 33), 2) a group of subjects with General Schizo-
typy scores between -1 and +1 SD (n = 85), and 3) a group
of subjects with General Schizotypy scores less than -1 SD
(n = 13). As it is clear from these numbers that the distri-
bution of scores is positively skewed (0.82), the use of SD
in dividing the sample is somewhat problematic. Never-
theless, we decided to maintain our criteria. All 33 high
scoring subjects, as well as 33 subjects randomly drawn
from the group with scores between -1 and +1 SD, were
invited to participate in a SPEM experiment. As at most 13
subjects of the low scoring group could be expected to par-
ticipate, this group was not invited.
A number of 25 subjects from the high scoring group and
22 from the group with 'average' scores were willing to
participate. These 47 subjects had a mean age of 37.30
years (SD = 7.33). There were no differences between the
two subgroups regarding sex and age. Due to the occur-
rence of eye blinks and the non-registration of pupil sizes
less than 2 mm, dependable SPEM data could be obtained
for 40 subjects: 19 individuals with elevated scores on
General Schizotypy and 21 persons with 'average' scores.
As three individuals – one from the high scoring and two
from the average scoring group – had outlying RMSE
scores in at least one of the three speed conditions men-
tioned below, the final sample consisted of 37 subjects.
The 18 subjects (9 females, 9 males) in the high schizo-
typy group had a mean age of 37.44 years (SD = 6.64), and
the 19 subjects (10 females, 9 males) with average schizo-
typy scores had a mean age of 36.11 years SD = of 6.83).
The two subsamples were not significantly different in age
and gender. Ethical approval for the study was obtained
from the review committee of the Faculty and all partici-
pants gave informed consent.
Procedure
SSQ and 4DPT measures
The SSQ [48] consists of 12 scales for the measurement of
the schizotypic symptoms Social Anxiety (SAN), Active
Isolation (AIS), Affective Flattening (AFF), Apathy (APA),
Alienation (ALN), Living in a Fantasy World (FTW), Ego-
centrism (EGC), Suspicion (SUS), Hostility (HOS), Cog-
nitive Derailment (CDR), Perceptual Disturbances (PER),
and Delusional Thinking (DET). As already indicated, the
instrument breaks down into three correlated factors –
Negative Schizotypy, Asocial Schizotypy, and Positive
Schizotypy. The general factor of the SSQ has loadings
from all scales, but particularly from scales that measure
negative symptoms. The SSQ demonstrates adequate reli-
ability, with Cronbach's alpha coefficients ranging from
0.77 to 0.91 in a sample of 771 general population sub-
jects. Meaningful correlations, attesting the construct
validity of the SSQ, were obtained by relating the 12 scales
to several other instruments, among which the Schizotypal
Personality Questionnaire [53] and the Dissociative Experi-
ences Scale-II [54]. The items of the SSQ, which are pre-
sented in the form of statements pertaining to behaviour
and feelings, must be answered on a four-point scale, indi-
cating the degree to which each statement applies to the
subject. The higher the scores on the 12 SSQ scales, the
higher the schizotypy.
The 4DPT or Four-Dimensional Personality Test [52] was
used to evaluate the validity of the SSQ. It was constructed
in an attempt to improve Eysenck's PEN model by show-
ing that his P or Psychoticism construct [55], as measured
by the Eysenck Personality Questionnaire, actually refers to
two distinct personality factors, S or Insensitivity and G or
Orderliness. In contrast, the factors E (Extraversion) and
N (Neuroticism) appeared to be 'non-problematic' and
could be retained. The 4DPT scales for S, E, N and G are
quite reliable and correlate with four of the five Big Five
dimensions. As it is known that the schizoid, schizotypal
or pre-schizophrenic personality is characterized by fea-
tures resembling high S and N positions, and a low posi-
tion on E [56-58], we expected the SSQ factor General
Schizotypy to be positively related with the 4DPT dimen-
sions S and N, negatively with E, and unrelated with G.
Oculomotor assessment
Eye movements were recorded by the Whittaker 1998-S
Eye View Monitor and TV Pupillometer System, an infra-
red video-pupillometric system (Whittaker Corporation,
Waltham, Massachusetts) [59]. This system generates
video images and values of horizontal and vertical posi-
tions. These positions are based on the measurement of
pupil size that is sampled with a frequency of 50 Hz. A
sampling frequency of 50 Hz is generally considered not
to be suited for measuring fast eye movements. However,
recently it was shown that video eye trackers sampling at
50 Hz are appropriate for detecting the clinical relevant
saccade peak velocities [60]. Thus, even with our low tem-
poral resolution of 50 Hz it is possible to measure pursuit
gain and saccades during pursuit. However, as it was our
purpose to relate a robust measure of SPEM dysfunctionPage 3 of 7
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sample frequency of 50 Hz may be suited to measure fast
eye movements, it can certainly considered appropriate
for the assessment of the RMSE.
Subjects were tested individually in a sound attenuated
room. They were instructed by the experimenter though
an intercom system. After a 7-min dark-adaptation period,
the testing procedure started. Each subject sat at a distance
of 57 cm in front of a monitor, the head restrained using
a chin rest. An infrared light camera, fastened in an oph-
thalmologic framework, was positioned at the height of
the subject's left eye limbus, registering left eye move-
ments and pupil size. Because of practical restrictions of
the pupillometric system, the measurement was unilateral
(left eye) and recordings could not be evaluated if the
pupil size was less than 2 mm. The pupil diameter resolu-
tion of the system was 1 part in 512 full scale. This size
was measured in mV, which value was divided by 50 to get
the pupil's diameter. Furthermore, no registrations were
retained in which no tracking occurred. The target that
consisted of a small square of white light that moved hor-
izontally on a black background screen was originally
positioned at the left site seen from the middle of the
monitor screen. The subject was instructed to follow the
target as carefully as possible and to try not to blink. After
one second and a half, the target began to move to the
right. The angle between the eye and the turning point was
15 degrees. In line with the study of Smyrnis et al. in
which RMSE was found to increase with increasing target
speed (10, 20 and 30 deg/s), we included targets with dif-
ferent speed [47].
Data analysis
The eye movement data were analysed under three condi-
tions of target speed. The lowest speed (L, 5°/s) was pre-
sented between 92,500 and 184,000 ms, the medium
speed (M, 10°/s) between 189,000 and 238,000 ms, and
the highest speed (H, 20°/s) between 248,000 and
284,000 ms. Eye movements were analysed only when the
target was moving but not during the 1 sec time the target
stand still and they were not taken into account in case of
too many eye blinks. As already indicated, we choose a
rather global measure of SPEM (dys)function, the root
mean square error score (RMSE) for eye vs. target position.
For each of the three conditions of target speed, an RMSE
score was calculated. In the analysis of the relationship
between General Schizotypy and SPEM dysfunction, we
first applied ANOVA with group (low vs. high General
Schizotypy) and target speed condition as repeated meas-
urements factor on RMSE scores. As three individuals
turned out to have outlying scores on RMSE in at least one
of the three conditions of target speed, 19 average scoring
subjects on General Schizotypy were actually compared
with 18 high scoring subjects. Secondly, we applied sepa-
rate ANOVAs with group as independent factor for each of
the target speed conditions. Similar analyses were per-
formed for pupil diameter. As for all target speeds more
SPEM deviations were expected to occur among individu-
als with higher scores on General Schizotypy, the statisti-
cal tests with respect to the SPEM data were one-tailed. As
we expected no relationship between pupil size and Gen-
eral Schizotypy, this relation was analysed by two-tailed
tests. Data were analysed using the SPSS version 14 soft-
ware package (SPSS inc., Chicago, USA).
Results
As expected the two subgroups scored significantly differ-
ent on the first unrotated SSQ factor (T (35) = -10.88, p <
0.0005, d = 3.5). The means of the estimated scores on
General Schizotypy is 1.80 (± 0.47) for the subgroup with
scores above 1 SD (n = 18) and 0.06 (± 0.50) for the sub-
group with scores between -1 and +1 SD (n = 19). In con-
trast to other studies defining the high schizotypy group as
scoring > 2 SD and the average schizotypy group as scor-
ing +/- 0.5 SD [28-30], the two groups in our study were
less clearly separated. However, the highly significant
effect and large effect size d indicates that our subgroups
differ substantially in schizotypy score. Also in line with
our expectations t-tests indicated that the high schizotypy
group scored significantly higher on the 4DPT dimen-
sions S and N and lower on E, whereas no differences were
observed on 4DPT-G (Mean Insensitivity, low schizotypy
group: S = 4.97 ± 3.46; high schizotypy group: S = 7.39 ±
4.21, p = 0.047; Mean Neuroticism, low schizotypy group:
N = 5.16 ± 4.07; high schizotypy group: N = 11.47 ± 2.85,
p < 0.0005; Mean Extraversion, low schizotypy group: E =
10.0 ± 4.17; high schizotypy group: E = 6.65 ± 4.57, p =
0.028). These findings are additional support of the valid-
ity of the SSQ measure.
ANOVA with Group as independent factor and Target
speed as repeated measurements factor indicated that the
high schizotypy group had significantly higher RMSE
scores than the average scoring group (F (1,35) = 5,68, p =
0.023, h2 = 0.14). In addition, no significant interaction
between Group and Target speed was found (Figure 1).
Univariate ANOVAs with Group as independent factor
indicated that for each target speed the high schizotypy
group had significantly higher RMSE scores than the aver-
age schizotypy group (Low speed: F(1,35) = 5.15, p =
0.015, h2 = 0.13; Medium speed: F(1,35) = 3.85, p = 0.029,
h2 = 0.1; High speed: F(1,35) = 5.05, p = 0.015, h2 = 0.13).
This finding indicates that under each target speed condi-
tion SPEM performance of the high schizotypy group was
significant worse than that of the average schizotypy
group. With respect to pupil diameter, ANOVA with
Group as independent factor and Target speed as repeated
measurements factor did neither indicate any significant
difference between groups nor any significant interaction
between Group and Target speed (Table 1).Page 4 of 7
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In this study we examined the relationship between sub-
jects' scores on the Schizotypic Syndrome Questionnaire
(SSQ) [48], pupil size and quality of smooth pursuit eye
movements (SPEM), one of the most dependable biolog-
ical markers of the genetic liability for schizophrenia [61].
In addition, to examine the effect of speed of the target on
this relationship, subjects were instructed to follow a hor-
izontally moving target under three conditions of speed.
To assess deviant eye tracking, we used a global measure,
the root mean square error score (RMSE) for eye vs. target
position. We expected that higher scores on the (general
factor of the) SSQ would be associated with more appar-
ent SPEM dysfunction. We had no specific expectations on
the relationship between target speed and magnitude of
SPEM dysfunction. Finally, we examined whether there
exists a relationship between General Schizotypy and
baseline pupil diameter.
As a sampling frequency of 50 Hz is not optimal for meas-
uring fast eye movements, the low temporal resolution
used in the present study is a limiting factor for data inter-
pretation. Therefore, conclusions drawn in the present
study must be regarded with some caution.
In line with our expectations, we found more SPEM dys-
function in subjects scoring high on the general SSQ fac-
tor. As this result appeared valid for all target speed
conditions, we may conclude that SPEM dysfunction in
high General Schizotypy subjects is irrespective of the
movement speed of the target. To interpret our findings
correctly, it is important to note that we compared SPEMs
of subjects scoring above 1 SD with subjects scoring
between -1 and +1 SD on schizotypy, whereas other, sim-
ilar studies made use of subjects scoring above 2 SD and
between -0.5 and +0.5 SD [28-30]. Hence, it seems plau-
sible to assume that the differences in SPEM dysfunction
would even have been more pronounced if we had used
these latter criteria. With respect to baseline pupil diame-
ter no differences were found between the high and aver-
age scoring groups on General Schizotypy. These results
are in agreement with what we expected.
As a measure for schizotypy we choose the SSQ concept of
General Schizotypy. based on the confirmation of a
model in subjects of the general population [43] and first-
episode schizophrenic patients [50]. The 12 symptom
scales of the SSQ constituted a network of causal relation-
ships validly describing the process of schizophrenic pro-
dromal unfolding and decompensation. As these scales
were found to give rise to three correlated factors, the gen-
eral factor of the SSQ was believed to present a dependa-
ble picture of the 'true' nature of schizotypy. Furthermore,
this choice was based on indications that, in addition to
the well-known relationship between negative symptoms
of SPD or schizophrenia and SPEM dysfunction, also pos-
itive symptoms may relate to SPEM impairments. From a
behavioural-genetic perspective these results are under-
standable as it is a generally accepted that the genetic pre-
disposition to schizophrenia expresses itself
predominantly in negative symptoms [31-36], although
weaker relationships with that vulnerability factor have
also been reported for positive symptoms [33]. There are
even studies that indicate a primary association with pos-
itive symptoms of SPD [37,38]. As the SSQ factor General
Schizotypy mainly pertains to negative symptoms, but
also includes positive aspects [48], this instrument was
considered to be quite suitable for use in the present
study.
Although some researchers have suggested that the global
quantitative RMSE may be more sensitive to SPEM dys-
function than precise quantitative parameters as pursuit
gain or frequency of different saccade types [45], global
and specific measures may in fact be complementary [62].
Several studies indicate that the underlying mechanism in
Means (M) ± Standard Errors (SE) of Root Mean Square Error (RMSE) score for low, medium or high t rget speed in g oups scoring verage o  high on SSQ-Gener l SchizotypyFig re 1
Means (M) ± Standard Errors (SE) of Root Mean 
Square Error (RMSE) score for low, medium or high 
target speed in groups scoring average or high on 
SSQ-General Schizotypy.
Table 1: Means (M) ± Standard Deviations (SD) of pupil diameter 
for low, medium or high target speed and ANOVA test results in 
groups scoring average or high on SSQ-General Schizotypy
Schizotypy
Average High F (1,35) p h2
Low speed 5.55 ± 0.97 5.39 ± 0.80 0.31 0.58 0.009
Medium speed 5.48 ± 0.96 5.27 ± 0.84 0.49 0.49 0.014
High speed 5.50 ± 0.96 5.26 ± 0.90 0.61 0.44 0.017Page 5 of 7
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tory saccades, reflecting a lack of inhibition in the system
controlling saccades and eye fixations [63]. Indeed, accu-
rate SPEM performance requires the subject to activate
neural systems involved in smooth pursuit tracking, while
simultaneously suppressing the activity of neurons
responsible for saccadic movements that would move the
eye ahead of the target. As the failure to suppress saccadic
anticipation of target motion during smooth pursuit may
be an aspect of SPEM dysfunction related to presumed risk
for schizophrenia [64], it may well be true that the SPEM
dysfunction we found in our subjects with elevated scores
for General Schizotypy may be partly due to this inability
to suppress saccadic anticipation, possibly mediated by
the prefrontal cortex. Indeed, it has been argued that the
frontal cortex may have a central role in the coordination
and synchronization of effective SPEM performance, and
attempts to characterize the basis of SPEM dysfunction in
schizophrenia have emphasized the role of the frontal
lobe in deviant SPEM performance [65,66]. However, as
the anterior and posterior cingulate and subcortical sys-
tems such as basal ganglia, thalamus, and cerebellum
have also been found to be involved in the smooth pur-
suit network [67], SPEM dysfunction in schizotypic sub-
jects may be related to impairments in a diversity of brain
areas.
Conclusion
By investigating the General Schizotypy factor of the SSQ,
the present study provides additional evidence that SPEM
dysfunction is associated with schizotypic symptoms and
is already observable in general population subjects scor-
ing high on that factor. We further conclude that SPEM
dysfunction may be used as an early diagnostic sign of
schizophrenia.
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